Publication
Article
Supplements and Featured Publications
Participating Faculty: Overcoming Barriers to HIV Prevention: Population Health Considerations on Optimizing PrEP Access
Key Takeaways
- Patrick Sullivan received grants and lecture fees from Gilead Sciences and Merck & Co., indicating potential conflicts of interest.
- Diana Brixner received honoraria and grants from Gilead Sciences, suggesting institutional conflicts of interest.
Patrick Sullivan, DVM, PhD
Professor
Department of Epidemiology
Rollins School of Public Health
Emory University
Atlanta, GA
Diana I. Brixner, PhD
Professor
Department of Pharmacotherapy
Founder
Pharmacotherapy Outcomes Research Center
University of Utah
Salt Lake City, UT
Jerika Lam, PharmD
Associate Professor
Department of Pharmacy Practice
School of Pharmacy
Chapman University
Irvine, CA
Alice Hsiao, PharmD
Senior Director
US Medical Affairs, Patient Access & Quality
Gilead Sciences, Inc
Foster City, CA
Faculty Disclosures
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Patrick Sullivan, DVM, PhD
GRANTS RECEIVED
Gilead Sciences, Inc; Merck & Co, Inc.
LECTURE FEES FOR SPEAKING AT THE INVITATIONS OF A COMMERCIAL SPONSOR
Gilead Sciences, Inc
Diana Brixner, PhD
HONORARIA
Gilead Sciences, Inc
INSTITUTIONAL CONFLICTS OF INTEREST
GRANTS RECEIVED
Gilead Sciences, Inc
Jerika T. Lam, PharmD
GRANTS RECEIVED
Gilead Sciences, Inc
HONORARIA
Gilead Sciences, Inc
INSTITUTIONAL CONFLICTS OF INTEREST
GRANTS RECEIVED
Gilead Sciences, Inc
Alice Hsiao, PharmD
EMPLOYMENT
Gilead Sciences, Inc
STOCK OWNERSHIP
Gilead Sciences, Inc
